The landscape of modern healthcare is undergoing a revolutionary transformation, driven by cell and gene therapy innovations shaping 2025. These cutting-edge innovations are redefining what’s possible in medicine, offering

Healthcare is undergoing a profound transformation, one that’s being shaped by the convergence of two of the most powerful technological forces of our time: Biotechnology and Artificial Intelligence (AI)

United Kingdom, October 6, 2025: AstraZeneca has entered into a licensing agreement worth up to $555 million with Algen Biotechnologies, a U.S.-based biotech firm that leverages artificial intelligence

Biotechnology continues to be a driving force in modern science, with red biotechnology standing out for its transformative role in medical research and patient care. As diseases evolve, healthcare demands

United Kingdom, 16-sept-2025: Hundreds of patients with a fast-growing form of lung cancer will soon gain access to a new treatment, after the National Institute for Health and Care Excellence

London, UK: The London Biotechnology Show, Europe’s premier platform dedicated to red biotechnology, is set to return for its third annual edition at Excel London on 9 –10 June

London, June 24: Last week, the London Biotechnology Show 2025 wrapped up a dynamic two-day run at ExCeL London, reaffirming its position as one of the most influential gatherings in

London, June 19: Day 1 at the London Biotechnology Show opened to a fantastic start, filled with thought-provoking discussions about crucial topics, groundbreaking innovations on display, a highly engaged community

London, June 17: With just one day to go, the second edition of the London Biotechnology Show (LBS) is set to return to ExCeL London on 18–19 June, uniting

Wahid Awad, Founder and CEO of Rosetta Omics, joined Muhammad Younis for an insightful discussion on the future of precision oncology. He highlighted the challenges of moving beyond standard treatments

United kingdom, On April 23: MHRA Grants Approval to First-Ever UK Treatment for Friedreich’s Ataxia The Medicines and Healthcare products Regulatory Agency (MHRA) has approved omaveloxolone (sold under the

United Kingdom, Apr 21, 2024: A significant advancement in surgical technology has been introduced at HCA Healthcare UK, as London Bridge Hospital becomes the first in the nation to offer

United Kingdom, 11 April 2025: The UK has begun a 12-month rollout of the most significant reform to its clinical trial regulations in over two decades. Signed into law, the

Dr Lestter Cruz Serrano, Head of Global Medical Affairs at Cognizant, joined Muhammad Younis for a thought-provoking session on the transformative role of AI and cloud-based technologies in healthcare. Dr

London, 14 April 2025: Scientists at King’s College London have successfully developed human teeth in the lab using cells derived from patients, potentially enabling adults to regrow lost teeth